Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 118Neoplasms 110Lung Neoplasms 65Colorectal Neoplasms 52Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Pancreatic Neoplasms 34Melanoma 33Ovarian Neoplasms 29Neoplastic Cells, Circulating 29Head and Neck Neoplasms 27Uterine Cervical Neoplasms 23Multiple Myeloma 20Glioma 20Colonic Neoplasms 20Sarcoma 19Carcinoma, Hepatocellular 19Leukemia, Myeloid, Acute 18Neoplasm Metastasis 17Lymphoma 15Glioblastoma 15Esophageal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Hematologic Neoplasms 14Leukemia 13Endometrial Neoplasms 13Myelodysplastic Syndromes 11Kidney Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11

Interventions

fludarabine 4Cyclophosphamide 4Specimen Handling 2Nivolumab 2Natalizumab 2Interferon beta-1b 2Fingolimod Hydrochloride 2Blood Specimen Collection 2teriflunomide 1nabiximols 1gadobutrol 1gadobenic acid 1cabozantinib 1Surveys and Questionnaires 1Respiratory Therapy 1Registries 1Platinum Compounds 1Platelet Transfusion 1Plasma Exchange 1Phlebotomy 1OM 89 1Mn-PyC3A 1Medical Marijuana 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Ipilimumab 1Interferon beta-1a 1Injections 1Gadolinium DTPA 1Fish Oils 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multiple Sclerosis × Blood Specimen Collection × Clear all
NCT00704626 2026-05-18

SAA

University of California, Davis

Enrolling by invitation
120 enrolled

Autoimmune Diseases, Multiple Sclerosis, Myasthenia Gravis, Myelitis, Transverse

NCT04844489 2023-02-06

COVIVAC-ID

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
377 enrolled

COVID-19, Multiple Sclerosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡